Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure

The coronavirus disease (COVID-19) pandemic is a global health priority. Given that cardiovascular diseases (CVD) are the leading cause of morbidity around the world and that several trials have reported severe cardiovascular damage in patients infected with SARS-CoV-2, a substantial number of COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Razeghian-Jahromi, Iman, Zibaeenezhad, Mohammad Javad, Lu, Zhibing, Zahra, Elyaspour, Mahboobeh, Razmkhah, Lionetti, Vicenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447089/
https://www.ncbi.nlm.nih.gov/pubmed/32844337
http://dx.doi.org/10.1007/s10741-020-10016-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447089/
https://www.ncbi.nlm.nih.gov/pubmed/32844337
http://dx.doi.org/10.1007/s10741-020-10016-2

Ejemplares similares